טוען...

Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

BACKGROUND: Recently, immune checkpoint inhibitors have shown survival advantage over chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). This meta-analysis was conducted to gather and analyze the available evidence (Evidence level I; Randomized Controlled Trials) comparing...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Medicine (Baltimore)
Main Authors: Khan, Muhammad, Lin, Jie, Liao, Guixiang, Tian, Yunhong, Liang, Yingying, Li, Rong, Liu, Mengzhong, Yuan, Yawei
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer Health 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113026/
https://ncbi.nlm.nih.gov/pubmed/30113497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011936
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!